OncoCyte (OCX) Stock Chart & Stock Price History $3.00 -0.03 (-0.99%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OncoCyte Stock Price Performance5 Day Performance-3.23%1 Month Performance-1.64%3 Month Performance+1.69%6 Month Performance+7.94%Year-To-Date Performance+20.00%1 Year Performance+27.66% Receive OCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here OCX Stock Chart for Saturday, November, 2, 2024 OCX Chart by TradingView OncoCyte Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$3.03$3.00-0.99%$3.04$2.9027,219 shs$50.49 million10/31/2024$3.02$3.03+0.33%$3.07$2.9910,943 shs$51.01 million10/30/2024$3.10$3.02-2.58%$3.08$3.003,893 shs$50.83 million10/29/2024$3.10$3.10$3.10$3.0219,996 shs$52.17 million10/28/2024$3.04$3.10+1.97%$3.16$3.0035,595 shs$52.17 million10/25/2024$3.05$3.04-0.33%$3.13$3.022,477 shs$51.16 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$3.11$3.05-1.93%$3.20$3.0462,853 shs$25.23 million10/23/2024$3.08$3.11+0.97%$3.15$3.0419,164 shs$25.73 million10/22/2024$3.12$3.08-1.28%$3.13$3.0411,306 shs$25.48 million10/21/2024$3.13$3.12-0.32%$3.20$3.0411,316 shs$25.81 million10/18/2024$3.12$3.13+0.32%$3.15$2.9910,236 shs$25.89 million10/17/2024$3.11$3.12+0.32%$3.26$2.9910,831 shs$25.81 million10/16/2024$3.12$3.11-0.32%$3.26$3.0391,290 shs$25.73 million10/15/2024$3.12$3.12$3.20$3.0430,447 shs$25.81 million10/14/2024$3.05$3.12+2.30%$3.19$3.0023,660 shs$25.81 million10/11/2024$3.10$3.05-1.61%$3.15$2.9832,328 shs$25.23 million10/10/2024$3.07$3.10+0.98%$3.15$2.9530,007 shs$25.65 million10/09/2024$3.04$3.07+0.99%$3.11$2.9638,094 shs$25.40 million10/08/2024$3.01$3.04+1.00%$3.15$2.9633,840 shs$25.15 million10/07/2024$2.89$3.01+4.15%$3.10$2.9883,716 shs$24.90 million10/04/2024$2.98$2.89-3.02%$2.95$2.8524,985 shs$23.91 million10/03/2024$3.05$2.98-2.30%$3.20$2.9440,297 shs$24.65 million10/02/2024$2.99$3.05+2.01%$3.05$2.8411,834 shs$25.23 million10/01/2024$2.85$2.99+4.91%$2.99$2.836,448 shs$24.74 million09/30/2024$2.88$2.85-1.04%$2.94$2.8215,273 shs$23.58 million09/27/2024$2.97$2.88-3.03%$2.99$2.8410,293 shs$23.83 million09/26/2024$2.93$2.97+1.37%$3.04$2.8215,591 shs$24.57 million09/25/2024$3.00$2.93-2.33%$3.01$2.8716,661 shs$24.24 million09/24/2024$3.15$3.00-4.76%$3.20$2.9041,141 shs$24.82 million09/23/2024$3.34$3.15-5.69%$3.30$3.107,077 shs$26.06 million09/20/2024$3.00$3.34+11.33%$3.34$2.9163,462 shs$27.63 million09/19/2024$2.95$3.00+1.69%$3.06$2.955,807 shs$24.82 million09/18/2024$3.11$2.95-5.14%$3.07$2.956,069 shs$24.41 million09/17/2024$3.15$3.11-1.27%$3.21$3.063,479 shs$25.73 million09/16/2024$3.08$3.15+2.27%$3.20$3.054,437 shs$26.06 million09/13/2024$3.10$3.08-0.65%$3.10$3.044,865 shs$41.18 million09/12/2024$3.10$3.10$3.10$3.045,020 shs$25.65 million09/11/2024$3.17$3.10-2.05%$3.10$3.045,020 shs$25.65 million09/10/2024$3.19$3.17-0.78%$3.20$3.008,592 shs$42.32 million09/09/2024$3.19$3.19$3.19$3.0314,607 shs$42.65 millionEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…09/06/2024$3.05$3.19+4.59%$3.23$3.076,675 shs$26.39 million09/05/2024$3.19$3.05-4.39%$3.19$3.052,817 shs$25.23 million09/04/2024$3.11$3.19+2.57%$3.20$3.0112,386 shs$26.39 million09/03/2024$3.14$3.11-0.96%$3.16$3.0019,286 shs$25.73 million09/02/2024$3.14$3.14$3.18$3.058,700 shs$25.98 million08/30/2024$3.14$3.14-0.09%$3.18$3.058,688 shs$25.98 million08/29/2024$3.03$3.14+3.72%$3.21$3.023,421 shs$26 million08/28/2024$3.14$3.03-3.50%$3.23$3.0011,493 shs$25.07 million08/27/2024$3.12$3.14+0.64%$3.19$2.928,687 shs$25.98 million08/26/2024$3.11$3.12+0.32%$3.22$3.093,977 shs$25.81 million08/23/2024$3.21$3.11-3.12%$3.22$2.915,223 shs$41.58 million08/22/2024$3.02$3.21+6.29%$3.23$3.111,842 shs$42.92 million08/21/2024$3.16$3.02-4.43%$3.24$3.022,808 shs$40.38 million08/20/2024$3.24$3.16-2.47%$3.28$3.143,813 shs$42.25 million08/19/2024$3.05$3.24+6.23%$3.24$3.0028,033 shs$43.32 million08/16/2024$2.95$3.05+3.39%$3.05$2.8450,194 shs$25.23 million08/15/2024$3.02$2.95-2.32%$3.03$2.894,739 shs$24.41 million08/14/2024$3.05$3.02-0.98%$3.02$2.972,827 shs$24.98 million08/13/2024$2.96$3.05+3.04%$3.05$2.8522,409 shs$25.23 million08/12/2024$3.12$2.96-5.13%$3.24$2.9613,083 shs$24.49 million08/09/2024$3.08$3.12+1.30%$3.34$2.9639,141 shs$25.81 million08/08/2024$3.00$3.08+2.67%$3.28$3.0034,100 shs$25.48 million08/07/2024$3.05$3.00-1.64%$3.12$2.9313,919 shs$24.82 million08/06/2024$2.87$3.05+6.27%$3.18$2.849,525 shs$25.23 million08/05/2024$2.95$2.87-2.71%$3.02$2.8011,869 shs$23.74 million08/02/2024$3.11$2.95-5.14%$3.13$2.8919,562 shs$24.40 million08/01/2024$3.14$3.11-0.96%$3.32$3.0518,711 shs$25.72 million Related Companies DURECT Stock Price Chart Achilles Therapeutics Stock Price Chart ImmuCell Stock Price Chart DBV Technologies Stock Price Chart Aspira Women's Health Stock Price Chart InflaRx Stock Price Chart Vincerx Pharma Stock Price Chart Gossamer Bio Stock Price Chart Instil Bio Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCX Stock Alerts